Newsletter
Profiling Prostate Cancer
Lab Technologist
The PSA assay for prostate cancer is notoriously inaccurate, opening the way for a better diagnostic of this major [MORE]
“Spritam:” the First Approved 3-D Printed Pill
Earlier this year, “Spritam,” an anti-epilepsy drug in a new formulation, from an Ohio biotech, became the first FDA approved [MORE]
Nanoparticle Drug Delivery
Platelet Nanoparticle
Much research is ongoing with nanoparticles for both drug delivery and gene therapy. This piece describes work in two [MORE]
First Artificial Ribosome
Ribosomes in a Cell
I almost missed this piece from last summer and it would have been a major oversight had [MORE]
J. Craig Venter’s $250 Genome for Consumers
J. Craig Venter
Entering the race to sequence the human genome after the government-sponsored team had a decade head start with [MORE]
3-D Printed Guide for Regrowing Nerves
This piece describes a nerve regeneration technique that may be a long way from clinical reality, or maybe not. Researchers [MORE]
Columbia University’s 467 Gene Targeted Cancer Panel
Illuminia HiSeq2500
The first was last when it came to sequencing human chromosomes. Work on Chromosome 1, the last, was completed [MORE]
Wait and See
Macular Degeneration
This past August, a patient at the Moorfield Eye Hospital in London underwent a two hour surgery which placed [MORE]
Understanding p53 in Tumor Cells
P53 Pathways
It could be the “holy grail” of cancer science if researchers figured out how to restore p53 tumor suppressor [MORE]
An Exercise Pill?
Exercising
“Compound 14” is the name biochemists at the University of Southampton (UK) have given to a molecule that initiates a [MORE]
Illumina’s “PopArray” for Population Health
DNA sequencing machine manufacturer Illumina (San Diego, CA) has taken a surprising step toward a competing technology, microarray, for a [MORE]
Tissue Scaffolds of Micropatterned Silk Protein Hydrogel
Laser
Regenerative medicine relies upon artificial scaffolds for producing cell growth into a desirable shape. That scaffold material has to have [MORE]
Ingestible Dye Makes Tumor Cells Glow
Neurosurgery
Distinguishing tumor from non-tumor cells in the brain is no easy task, even with the best imaging machines. And for [MORE]
90% of Advanced Prostate Cancers have Clinically Actionable Genetic Aberrations
Genetic Counseling
In a collaboration involving eight centers in the US and Europe, researchers sequenced DNA and RNA from tissue biopsies [MORE]